Former Chief Financial Officer · Sagimet Biosciences Inc. (SGMT)

Dennis Hom

A named executive officer of Sagimet Biosciences in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$745,507

Salary $226,069Stock awards $0

FY2022: $466,892

4th of 4 named executive officers at Sagimet Biosciences by FY2023 total.

4 named officers on file for Sagimet Biosciences, FY2023

Dennis Hom’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Sagimet Biosciences’s whole pay program stands against its peers

  • Sagimet Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on SGMT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 18, 2024 (DEF 14A).

Free

Get Dennis Hom’s full pay file as a PDF — free

More than this page: up to 10 years of Dennis’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Dennis Hom compensation by year

Sagimet Biosciences Summary Compensation Table · all 2 fiscal years held
In US dollars, as Sagimet Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$357,473$226,069
Bonus$0$0
Stock awards$0$0
Option awards$0$0
Non-equity incentive$109,351—
Pension and deferred compensation$0$0
All other$68$519,438
Total$466,892$745,507

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Sagimet Biosciences Inc. DEF 14A filed April 18, 2024, accession 0001104659-24-048534, and prior-year filings.

How this page was built: the Sagimet Biosciences Inc. filed document, accession 0001104659-24-048534. Every figure is read from that document and cited to the page and table it appears in. Filed April 18, 2024.

$467K
$746K
FY22
FY23
SalaryNon-equity incentiveAll other

Sagimet Biosciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
David HappelPresident and Chief Executive Officer$2,685,917
Eduardo MartinsChief Medical Officer$1,509,081
George KembleExecutive Chairman and former President, Chief Executive Officer and Chief Scientific Officer$930,223
Dennis Hom · this pageFormer Chief Financial Officer$745,507

The full Sagimet Biosciences compensation record

free company brief

This page is one person within Sagimet Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Sagimet Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Dennis Hom's compensation dossier · One-time report. No refunds.